CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$2.50
+167.58%
12-Month target
—
—
Intrinsic (DCF)
$9.22
Margin of safety
+86.66%
Price chart
X-Ray snapshot
Strengths
+ 86.66% below intrinsic value
Risks
- Thin margins at -198.80%
- Negative free cash flow $-4.21M
- Revenue declining -43.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $21.34M | $17.98M | $22.77M | $54.22M | $40.58M |
| Net income | $-100.12M | $14.19M | $-196.29M | $-57.89M | $-23.07M |
| EPS | — | — | — | — | $-3.33 |
| Free cash flow | $-116.30M | $-143.11M | $-42.73M | $-6.56M | $-4.21M |
| Profit margin | -469.27% | 78.95% | -862.04% | -106.77% | -198.80% |
Peer comparison
Smart narrative
Celularity Inc trades at $0.93. Our Smart Value Score of 19/100 indicates the stock is weak. TTM revenue stands at $40.58M. with profit margins at -198.80%. Our DCF model estimates intrinsic value at $9.22.
Frequently asked questions
What is Celularity Inc's stock price?
Celularity Inc (CELU) trades at $0.93.
Is Celularity Inc overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell). DCF value $9.22.
What is the price target of Celularity Inc (CELU)?
The analyst target price is $2.50, representing +167.6% upside from the current price of $0.93.
What is the intrinsic value of Celularity Inc (CELU)?
Based on our DCF model, intrinsic value is $9.22, a +86.7% margin of safety versus $0.93.
What is Celularity Inc's revenue?
TTM revenue is $40.58M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.79x
ROE-6,367.00%
Beta0.71
50D MA$1.27
200D MA$1.90
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—